title: Third consensus on medical treatment of metastatic breast cancer.
abstract: BACKGROUND
  Treatment options for patients with metastatic breast cancer (MBC) include a rapidly expanding repertoire of medical, surgical and supportive care measures.
  
  
  METHODS
  To provide timely and evidence-based recommendations for the diagnostic workup and treatment of patients with MBC, an international expert panel reviewed and discussed the evidence available from clinical trials regarding diagnostic, therapeutic and supportive measures with emphasis on their impact on the quality of life and overall survival of patients with MBC.
  
  
  RESULTS
  Evidence-based recommendations for the diagnostic workup, endocrine therapy, chemotherapy, use of targeted therapies and bisphosphonates, surgical treatment and supportive care measures in the management of patients with MBC were formulated.
  
  
  CONCLUSIONS
  The present consensus manuscript updates evidence-based recommendations for state-of-the-art treatment of MBC depending on disease-associated and biological variables.
authors.affiliation: Institute of Oncology, Sarajevo, Bosnia and Herzegovina, France.
authors.forename: S
authors.initials: S
authors.lastname: Beslija
authors.forename: J
authors.initials: J
authors.lastname: Bonneterre
authors.forename: H J
authors.initials: HJ
authors.lastname: Burstein
authors.forename: V
authors.initials: V
authors.lastname: Cocquyt
authors.forename: M
authors.initials: M
authors.lastname: Gnant
authors.forename: V
authors.initials: V
authors.lastname: Heinemann
authors.forename: J
authors.initials: J
authors.lastname: Jassem
authors.forename: W J
authors.initials: WJ
authors.lastname: Köstler
authors.forename: M
authors.initials: M
authors.lastname: Krainer
authors.forename: S
authors.initials: S
authors.lastname: Menard
authors.forename: T
authors.initials: T
authors.lastname: Petit
authors.forename: L
authors.initials: L
authors.lastname: Petruzelka
authors.forename: K
authors.initials: K
authors.lastname: Possinger
authors.forename: P
authors.initials: P
authors.lastname: Schmid
authors.forename: E
authors.initials: E
authors.lastname: Stadtmauer
authors.forename: M
authors.initials: M
authors.lastname: Stockler
authors.forename: S
authors.initials: S
authors.lastname: Van Belle
authors.forename: C
authors.initials: C
authors.lastname: Vogel
authors.forename: N
authors.initials: N
authors.lastname: Wilcken
authors.forename: C
authors.initials: C
authors.lastname: Wiltschke
authors.forename: C C
authors.initials: CC
authors.lastname: Zielinski
authors.forename: H
authors.initials: H
authors.lastname: Zwierzina
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008408:Mastectomy; D015201:Meta-Analysis as Topic; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents